The Trump administration has placed an order for 100 million doses of a coronavirus vaccine, with the option to purchase an additional 500 million doses.
In a joint statement, Pfizer and BioNTech announced that they secured “an agreement with the U.S. Department of Health and Human Services and the Department of Defense to meet the U.S. government’s Operation Warp Speed program goal to begin delivering 300 million doses of a vaccine for COVID-19 in 2021.”
“Under the agreement, the U.S. government will receive 100 million doses of BNT162, the COVID-19 vaccine candidate jointly developed by Pfizer and BioNTech, after Pfizer successfully manufactures and obtains approval or emergency use authorization from U.S. Food and Drug Administration (FDA),” the statement added. “Americans will receive the vaccine for free consistent with U.S. government’s commitment for free access for COVID-19 vaccines.”
According to the Wall Street Journal, “The BNT162 program is based on BioNTech’s proprietary mRNA technology and supported by Pfizer’s global vaccine development and manufacturing capabilities. The BNT162 vaccine candidates are undergoing clinical studies and aren’t currently approved for distribution anywhere in the world.”
They continue, “The Pfizer-BioNTech vaccine development program is evaluating at least four experimental vaccines. If the studies are successful, Pfizer and BioNTech expect to seek emergency use authorization or some form of regulatory approval as early as October.”